Gospodarowicz D, Mescher A L, Birdwell C R
Natl Cancer Inst Monogr. 1978 May(48):109-30.
Recent studies on the effect of the fibroblast and epidermal growth factors (FGF and EGF, respectively) on the proliferation of ovarian cells and vascular endothelial cells are reviewed. During the ovarian cycle, luteal cells are derived from granulosa cells by a process of cytomorphosis. These two cell types thus allow a study of the changes that occur in growth control when one cell type is converted into another. Also described is the control of vascular endothelial cell proliferation by FGF (but not by EGF). We discuss the effects of FGF and EGF on cells derived from the embryonic ectoderm, mesoderm, and endoderm and examine the hypothesis that cellular specificity for various growth factors is conferred during embryo development. Finally, since antagonists of growth factors are probably as important as the mitogens in the overall control of cell proliferation, we review certain mechanisms and agents through which the mitogenic effect of FGF can be repressed, i.e., cell-cell interaction at confluence, trophic hormones, and a diffusible factor(s) from cartilage.
本文综述了近期关于成纤维细胞生长因子和表皮生长因子(分别为FGF和EGF)对卵巢细胞和血管内皮细胞增殖影响的研究。在卵巢周期中,黄体细胞通过细胞变形过程由颗粒细胞衍生而来。因此,这两种细胞类型有助于研究当一种细胞类型转变为另一种细胞类型时生长控制中发生的变化。文中还描述了FGF(而非EGF)对血管内皮细胞增殖的控制。我们讨论了FGF和EGF对源自胚胎外胚层、中胚层和内胚层的细胞的影响,并检验了在胚胎发育过程中赋予各种生长因子细胞特异性的假说。最后,由于生长因子拮抗剂在细胞增殖的整体控制中可能与促有丝分裂原同样重要,我们综述了某些可抑制FGF促有丝分裂作用的机制和因子,即汇合时的细胞间相互作用、营养激素以及来自软骨的一种或多种可扩散因子。